Recommendations from The Medical Education Editor
Respirology · 2024
DOI: 10.1111/resp.14640 ↗At a glance
Editorial in Respirology, 2024. Written by Mark Lavercombe. Institution: Department of Respiratory & Sleep Disorders Medicine, Western Health, Melbourne, Victoria, Australia. Major MEDLINE topics: Asthma, Education, Medical. 12 references.
Abstract (original language)
benralizumab-and non-response was infrequent at 11.3% and 12.8%, respectively.Patients treated with benralizumab appeared to have a more significant reduction in exacerbation frequency and increase in FEV1 than those treated with mepolizumab.Although observational in nature, these data suggest the need for further investigation of potential differences between the anti-IL5 treatments.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Respiratory & Sleep Disorders Medicine, Western Health, Melbourne, Victoria, Australia.
- Department of Medical Education, Melbourne Medical School, The University of Melbourne, Melbourne, Victoria, Australia.
ORCID profiles: Mark Lavercombe
Cite
APA
Lavercombe, M. (2024). Recommendations from The Medical Education Editor. Respirology. https://doi.org/10.1111/resp.14640
Vancouver
Lavercombe M. Recommendations from The Medical Education Editor. Respirology. 2024. doi:10.1111/resp.14640
BibTeX
@article{Lavercombe2024,
author = {Lavercombe, Mark},
title = {Recommendations from The Medical Education Editor},
journal = {Respirology},
year = {2024},
doi = {10.1111/resp.14640}
}
EUVIMED